IS2349B - Lyfjafræðileg drónedarón samsetning til gjafar utan meltingarvegar - Google Patents

Lyfjafræðileg drónedarón samsetning til gjafar utan meltingarvegar

Info

Publication number
IS2349B
IS2349B IS6801A IS6801A IS2349B IS 2349 B IS2349 B IS 2349B IS 6801 A IS6801 A IS 6801A IS 6801 A IS6801 A IS 6801A IS 2349 B IS2349 B IS 2349B
Authority
IS
Iceland
Prior art keywords
pharmacological
parenteral administration
dronedarone
composition
dronedarone composition
Prior art date
Application number
IS6801A
Other languages
English (en)
Other versions
IS6801A (is
Inventor
Bourriague-Seve Frédérique
Breul Thierry
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of IS6801A publication Critical patent/IS6801A/is
Publication of IS2349B publication Critical patent/IS2349B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IS6801A 2000-12-11 2003-04-30 Lyfjafræðileg drónedarón samsetning til gjafar utan meltingarvegar IS2349B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0016071A FR2817750B1 (fr) 2000-12-11 2000-12-11 Composition pharmaceutique de dronedarone pour administration parenterale
PCT/FR2001/003903 WO2002047660A1 (fr) 2000-12-11 2001-12-10 Composition pharmaceutique de dronedarone pour administration parenterale

Publications (2)

Publication Number Publication Date
IS6801A IS6801A (is) 2003-04-30
IS2349B true IS2349B (is) 2008-04-15

Family

ID=8857483

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6801A IS2349B (is) 2000-12-11 2003-04-30 Lyfjafræðileg drónedarón samsetning til gjafar utan meltingarvegar

Country Status (30)

Country Link
US (1) US6939865B2 (is)
EP (1) EP1343473B1 (is)
JP (1) JP4399161B2 (is)
KR (1) KR100849758B1 (is)
CN (1) CN1235566C (is)
AR (1) AR031649A1 (is)
AT (1) ATE348599T1 (is)
AU (2) AU2002217229B2 (is)
BG (1) BG66187B1 (is)
BR (1) BR0116060B1 (is)
CA (1) CA2427375C (is)
CZ (1) CZ297788B6 (is)
DE (1) DE60125411T2 (is)
EA (1) EA005314B1 (is)
FR (1) FR2817750B1 (is)
HU (1) HU229372B1 (is)
IL (2) IL155428A0 (is)
IS (1) IS2349B (is)
MA (1) MA26969A1 (is)
ME (2) ME00083B (is)
MX (1) MXPA03005221A (is)
NO (1) NO332294B1 (is)
NZ (1) NZ525661A (is)
OA (1) OA12416A (is)
PL (1) PL199846B1 (is)
RS (1) RS50348B (is)
SK (1) SK287115B6 (is)
TW (1) TWI246926B (is)
WO (1) WO2002047660A1 (is)
ZA (1) ZA200303406B (is)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR059574A1 (es) * 2006-02-14 2008-04-16 Wyeth Corp Formulaciones farmaceuticas acuosas de ligandos selectivos er-beta
GB0719180D0 (en) 2007-10-02 2007-11-14 Cambrex Karlskoga Ab New process
TWI519298B (zh) 2008-04-17 2016-02-01 賽諾菲 安萬特公司 決奈達隆（ｄｒｏｎｅｄａｒｏｎｅ）於製備用於預防心血管疾病住院或死亡之藥劑之用途
FR2930149B1 (fr) * 2008-04-17 2011-02-18 Sanofi Aventis Association de dronedarone avec au moins un diuretique, son application en therapeutique
EP2116239A1 (en) * 2008-04-29 2009-11-11 Sanofi-Aventis Method for managing the risks associated with an increase in serum creatinine during dronedarone treatment
FR2959132A1 (fr) * 2010-04-22 2011-10-28 Sanofi Aventis Procedes pour l'evaluation et la reduction des risques
TWI508726B (zh) 2009-12-21 2015-11-21 Gilead Sciences Inc 治療心房纖維性顫動之方法
US20120005128A1 (en) * 2010-06-29 2012-01-05 Sanofi Methods for reducing the risk of an adverse dronedarone / calcium channel blockers interaction in a patient suffering from atrial fibrilation
US8602215B2 (en) 2010-06-30 2013-12-10 Sanofi Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation
CN102342907A (zh) 2010-07-30 2012-02-08 江苏恒瑞医药股份有限公司 决奈达隆固体分散体及其制备方法
KR20120094557A (ko) * 2011-02-01 2012-08-27 동아제약주식회사 피에이치 비의존적 용출양상을 갖는 부정맥치료제 제제
CN102908307A (zh) * 2011-08-03 2013-02-06 天津市嵩锐医药科技有限公司 供注射用盐酸决奈达隆药物组合物及其制备方法
CN104470500A (zh) * 2012-07-12 2015-03-25 赛诺菲 包含1-(6-{[6-(4-氟苯基)[1,2,4]三唑并[4,3-b]哒嗪-3-基]硫基}-1,3-苯并噻唑-2-基)-3-(2-吗啉-4-基乙基)尿素化合物的抗肿瘤组合物
WO2022083636A1 (zh) * 2020-10-20 2022-04-28 上海博志研新药物技术有限公司 盐酸决奈达隆药物组合物、其制备方法及应用
WO2023019993A1 (zh) * 2021-08-16 2023-02-23 上海博志研新药物技术有限公司 盐酸决奈达隆注射组合物、其制备方法及应用
CA3243121A1 (en) * 2022-12-07 2025-04-08 Remegen Co., Ltd. TACI-FC Liquid Pharmaceutical Preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
FR2746013B1 (fr) * 1996-03-18 1998-05-29 Sanofi Sa Utilisation de composes antiarythmiques dans la prevention de la mortalite post infarctus
JP2004327321A (ja) * 2003-04-25 2004-11-18 Jst Mfg Co Ltd コネクタ

Also Published As

Publication number Publication date
CZ20031612A3 (cs) 2003-09-17
IL155428A0 (en) 2003-11-23
IS6801A (is) 2003-04-30
PL199846B1 (pl) 2008-11-28
KR20030060985A (ko) 2003-07-16
DE60125411D1 (de) 2007-02-01
MXPA03005221A (es) 2004-03-26
AU2002217229B2 (en) 2006-05-18
EP1343473A1 (fr) 2003-09-17
ATE348599T1 (de) 2007-01-15
HUP0500842A2 (hu) 2005-12-28
DE60125411T2 (de) 2007-10-11
CN1235566C (zh) 2006-01-11
BR0116060B1 (pt) 2013-12-31
AU1722902A (en) 2002-06-24
NZ525661A (en) 2004-11-26
CN1479610A (zh) 2004-03-03
IL155428A (en) 2007-10-31
JP2004528277A (ja) 2004-09-16
US20040044070A1 (en) 2004-03-04
OA12416A (fr) 2006-04-18
SK287115B6 (sk) 2009-12-07
NO20031958L (no) 2003-06-11
BG66187B1 (bg) 2011-12-30
CZ297788B6 (cs) 2007-03-28
MEP20408A (en) 2010-06-10
TWI246926B (en) 2006-01-11
BG107748A (bg) 2004-03-31
FR2817750A1 (fr) 2002-06-14
NO332294B1 (no) 2012-08-20
FR2817750B1 (fr) 2003-02-21
ZA200303406B (en) 2004-05-03
YU46503A (sh) 2006-08-17
BR0116060A (pt) 2004-03-02
MA26969A1 (fr) 2004-12-20
CA2427375C (fr) 2011-02-01
EA005314B1 (ru) 2004-12-30
EA200300406A1 (ru) 2003-10-30
ME00083B (me) 2010-10-10
JP4399161B2 (ja) 2010-01-13
HK1055906A1 (en) 2004-01-30
US6939865B2 (en) 2005-09-06
EP1343473B1 (fr) 2006-12-20
CA2427375A1 (fr) 2002-06-20
PL362788A1 (en) 2004-11-02
KR100849758B1 (ko) 2008-07-31
HU229372B1 (en) 2013-11-28
NO20031958D0 (no) 2003-04-29
WO2002047660A1 (fr) 2002-06-20
RS50348B (sr) 2009-11-10
AR031649A1 (es) 2003-09-24
SK7262003A3 (en) 2004-02-03

Similar Documents

Publication Publication Date Title
IS2349B (is) Lyfjafræðileg drónedarón samsetning til gjafar utan meltingarvegar
DK1399127T3 (da) Olopatadinformuleringer til topisk administration
EE200100420A (et) Kütusekoostis
EP1325611A4 (en) IMPROVED DIRECTORY ASSISTANCE SYSTEM
FI991485L (fi) Uusi farmaseuttinen koostumus
FR09C0013I2 (fr) Nouveaux derives de phenyle-propargylether
ATA16182001A (de) Einbau-wölb-verwind-stütze
ATE295081T1 (de) Hilfsstoff-zusammensetzung
IS6571A (is) Samsett lyfjameðferð
AU2002217229A1 (en) Pharmaceutical dronedarone composition for parenteral administration
ITMI20011637A0 (it) Composizione farmaceutica contenente citalopram
NO20025474D0 (no) Benzofuranderivater
IT249776Y1 (it) Isolatore passante monolitico
DE60104098D1 (de) Brennstoffzusammensetzung
ATE273973T1 (de) Benzofuranderivate
NO990120L (no) Nye formuleringer for oromukosal, sµrlig pernasal rute
DE50013696D1 (de) Trennschalter
ITMI20000429A0 (it) Montante per quadro elettrico
ITFI20000148A0 (it) Traversina per strutture canaliformi
ITMC20000018A1 (it) Basamento prefabbricato per delimitatore stradale.
SE0004458D0 (sv) Pharmaceutically useful compounds
SE0002922D0 (sv) Pharmaceutically useful compounds
SE0002921D0 (sv) Pharmaceutically useful compounds
ITTO20000412A0 (it) Gruppo di sostegno per canali di gronde.
ITTO20000413A0 (it) Gruppo di sostegno per canali di gronde.